Efficacité de la mianserine dans le traitement de la schizophrénieWAKAMATSU, N.Yakuri to chiryo. 1987, Vol 15, Num 12, pp 445-464, issn 0386-3603Article

THE HUMAN PHARMACOLOGY OF GB94-A NEW PSYCHOTROPIC AGENT = ACTIVITE PHARMACOLOGIQUE CHEZ L'HOMME DU GB94, UN NOUVEAU PSYCHOTROPEFELL PJ; QUANTOCK DC; VAN DER BURG WJ et al.1973; EUROP. J. CLIN. PHARMACOL.; GERM.; DA. 1973; VOL. 5; NO 3; PP. 166-173; BIBL. 1 P.Serial Issue

The effect of mianserin on alpha-2 adrenergic receptor function in depressed patientsCHARNEY, D. S; HENINGER, G. R; STERNBERG, D. E et al.British journal of psychiatry (Print). 1984, Vol 144, pp 407-416, issn 0007-1250, INDEXArticle

PROCEEDINGS OF THE SECOND SYMPOSIUM ON MIANSERIN, JERSEY APRIL 19821983; BR. J. CLIN. PHARMACOL.; ISSN 0306-5251; GBR; DA. 1983; VOL. 15; SUPPL. NO 2; PP. 146-341; BIBL. DISSEM.Conference Paper

ANTIDEPRESSANT DRUGSBLACKWELL B.1980; SIDE EFF. DRUGS ANN.; NLD; DA. 1980; VOL. 4; PP. 17-21; BIBL. 30 REF.Article

MIANSERIN AND AGRANULOCYTOSISCURSON DA; HALE AS.1979; BRIT. MED. J.; GBR; DA. 1979; NO 6160; PP. 378-379; BIBL. 6 REF.Article

Effects of the antidepressant mianserin in zebrafish : Molecular markers of endocrine disruptionVAN DER VEN, Karlijn; KEIL, Dorien; MOENS, Lotte N et al.Chemosphere (Oxford). 2006, Vol 65, Num 10, pp 1836-1845, issn 0045-6535, 10 p.Article

Hépatotoxicité de la miansérine : un cas avec réintroduction positiveBARBARE, J.-C; BIOUR, M; CADOT, T et al.Gastroentérologie clinique et biologique. 1992, Vol 16, Num 5, pp 486-488, issn 0399-8320Article

Antidepressant drugs: imipramine, mianserin and trazodoneBOSCHMANS, S.-A; PERKIN, M. F; TERBLANCHE, S. E et al.Comparative biochemistry and physiology. C. Comparative pharmacology. 1987, Vol 86, Num 2, pp 225-232, issn 0306-4492Article

New implications of antidepressant therapy in neuropsychopharmacology: focus on mianserin: papers/14th CINP congress, Florence, Italy, 19-23 June 1984BURROWS, G. D; AGNOLI, A.Acta psychiatrica scandinavica. Supplementum. 1985, Vol 72, Num 320, issn 0065-1591, V-105 pConference Proceedings

SECOND GENERATION ANTIDEPRESSANTS: THE PHARMACOLOGICAL AND CLINICAL SIGNIFICANCE OF SELECTED EXAMPLESMAXWELL RA.1983; DRUG DEVELOPMENT RESEARCH; ISSN 0272-4391; USA; DA. 1983; VOL. 3; NO 3; PP. 203-211; BIBL. 2 P.Article

MIANSERIN: DETERMINATION OF THERAPEUTIC DOSE RANGEPETRIE WM; WILSON WH; BAN TA et al.1980; INT. PHARMACOPSYCHIATRY; ISSN 0020-8272; CHE; DA. 1980; VOL. 15; NO 2; PP. 111-117; BIBL. 7 REF.Article

UN NOUVEL ANTIDEPRESSEUR DE GRANDE MANIABILITE: L'ATHYMILGRIVOIS H; BILLON A.1980; VIE MED.; FRA; DA. 1980; VOL. 61; NO 10; PP. 859-861Article

CARDIOVASCULAR TOLERANCE OF MIANSERIN AND INTERACTIONS OF MANSERIN WITH OTHER DRUGSKOPERA H.1978; ACTA PSYCHIATR. BELG; BEL; DA. 1978; VOL. 78; NO 5; PP. 787-797; ABS. FRE/DUT/GER/ITA/SPA; BIBL. 1 P.Conference Paper

GLI ANTIDEPRESSIVI DELLA TERZA GENERAZIONE: ESPERIENZA DI 100 CASI DI DEPRESSIONE PRIMARIA BRATTATI CON VILOXAZINA, NOMIFENSINA E MIANSERINA = LES ANTIDEPRESSEURS DE LA TROISIEME GENERATION: EXPERIENCES SUR 100 CAS DE DEPRESSION PRIMAIRE AVEC LA VILOXAZINE, LA NOMIFENSINE ET LA MIANSERINEFARAVELLI C; TONINI R; ZACCARA G et al.1981; MINERVA PSICHIATR.; ISSN 0391-1772; ITA; DA. 1981; VOL. 22; NO 2; PP. 79-83; ABS. ENG; BIBL. 27 REF.Article

NOUVEAUTES THERAPEUTIQUESLESIEUR D; LESIEUR DEMARQUILLY I.1979; BULL. SOC. PHARM. LILLE; FRA; DA. 1979; VOL. 35; NO 4; PP. 195-215Article

MIANSERIN VERSUS AMITRIPTYLINE. A DOUBLE-BLIND-TRIAL EVALUATED BY THE AMP SYSTEMVOGEL HP; BENTE D; FEDER J et al.1976; INTERNATION. PHARMACOPSYCHIATRY; SWITZ.; DA. 1976; VOL. 11; NO 1; PP. 25-31; BIBL. 6 REF.Article

Personality traits predict treatment outcome with an antidepressant in patients with functional gastrointestinal disorderTANUM, L; MALT, U. F.Scandinavian journal of gastroenterology. 2000, Vol 35, Num 9, pp 935-941, issn 0036-5521Article

Correlation between steady-state plasma concentrations of mianserin and trazodone in depressed patientsOTANI, K; TYBRING, G; MIHARA, K et al.European journal of clinical pharmacology. 1998, Vol 53, Num 5, pp 347-349, issn 0031-6970Article

Venlafaxine's effects on healthy volunteers' driving, psychomotor, and vigilance performance during 15-day fixed and incremental dosing regimensO'HANLON, J. F; ROBBE, H. W. J; VERMEEREN, A et al.Journal of clinical psychopharmacology. 1998, Vol 18, Num 3, pp 212-221, issn 0271-0749Article

Effects of thioridazine, an inhibitor of CYP2D6, on the steady-state plasma concentrations of the enantiomers of mianserin and its active metabolite, desmethylmianserin, in depressed Japanese patientsYASUI, N; TYBRING, G; OTANI, K et al.Pharmacogenetics (London). 1997, Vol 7, Num 5, pp 369-374, issn 0960-314XArticle

Involvement of the α₂-adrenergic system in polydipsia in schizophrenic patients : a pilot studyHAYASHI, T; NISHIKAWA, T; KOGA, I et al.Psychopharmacologia. 1997, Vol 130, Num 4, pp 382-386, issn 0033-3158Article

AkathisiaFRIEDMAN, E. H.British journal of psychiatry (Print). 1990, Vol 156, Num FEVR, pp 285-285, issn 0007-1250, 1 p.Article

SECOND GENERATION OF ANTIDEPRESSANTSLEONARD BE.1981; ADV. BIOL. PSYCHIATRY; ISSN 0378-7354; CHE; DA. 1981; VOL. 7; PP. 173-186; BIBL. 4 P.Article

ADVERSE EFFECTS OF ANTIDEPRESSANT DRUGS. II: "SECOND GENERATION" ANTIDEPRESSANTS AND RATIONAL DECISION MAKING IN ANTIDEPRESSANT THERAPYBLACKWELL B.1981; DRUGS (N. Y.); ISSN 0012-6667; USA; DA. 1981; VOL. 21; NO 4; PP. 273-282; BIBL. 4 P.Article